BIOMAT Database Logo BIOMAT Database Logo

[Intra-arterial injection therapy of mitoxantrone for locally advanced breast cancer]. 1998

W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
Second Dept. of Surgery, Tokyo Medical and Dental University.

Mitoxantrone (MIT) is a new anthraquinone anticancer agent. We treated 14 patients with locally advanced breast cancer, 3 of which were inflammatory breast cancers, by pre-operative arterial injection of MIT. The treatment protocol was MIT 12 mg/m2 injected into both the internal mammary and the subclavian arteries with oral administration of 5'-DFUR 1,200 mg/day for 20 days. After 2 courses, all tumors were decreased over 50% in size. Down-staging was obtained in all of 8 cases. Mastectomy could be carried out on all patients, without microscopically residual tumor cells. Preoperative arterial injection of MIT might be the treatment of choice for locally advanced breast cancer to perform down-staging, however the survival benefit has remained equivocal. These preliminary results are encouraging to further studies.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008408 Mastectomy Surgical procedure to remove one or both breasts. Mammectomy,Mammectomies,Mastectomies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008942 Mitoxantrone An anthracenedione-derived antineoplastic agent. Mitozantrone,CL-232325,DHAQ,Mitoxantrone Acetate,Mitoxantrone Hydrochloride,Mitroxone,NSC-279836,NSC-287836,NSC-299195,NSC-301739,NSC-301739D,Novantron,Novantrone,Onkotrone,Pralifan,Ralenova,Acetate, Mitoxantrone,CL 232325,CL232325,Hydrochloride, Mitoxantrone,NSC 279836,NSC 287836,NSC 299195,NSC 301739,NSC 301739D,NSC279836,NSC287836,NSC299195,NSC301739,NSC301739D
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002408 Catheters, Indwelling Catheters designed to be left within an organ or passage for an extended period of time. Implantable Catheters,In-Dwelling Catheters,Catheter, In-Dwelling,Catheter, Indwelling,Catheters, In-Dwelling,In Dwelling Catheters,In-Dwelling Catheter,Indwelling Catheter,Indwelling Catheters
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females

Related Publications

W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
[Preoperative intra-arterial injection of mitoxantrone for locally advanced breast cancer].
August 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
January 2003, Anticancer research,
W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
Neoadjuvant intra-arterial infusion chemotherapy combined with hormonal therapy for locally advanced breast cancer.
January 2000, Oncology reports,
W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
Toxicity of intra-arterial doxorubicin in locally advanced breast cancer.
January 1990, Cancer chemotherapy and pharmacology,
W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
[Preoperative intra-arterial chemotherapy with THP-ADR for locally advanced breast cancer].
September 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
[Intra-arterial chemotherapy for locally advanced bladder cancer].
February 1999, Hinyokika kiyo. Acta urologica Japonica,
W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
Intra-arterial cytotoxic therapy and radiotherapy for locally advanced breast cancer. Interim report of a trial.
January 1975, Panminerva medica,
W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
[Intra-arterial infusion chemotherapy with docetaxel for locally advanced breast cancer and inflammatory breast cancer].
October 2000, Gan to kagaku ryoho. Cancer & chemotherapy,
W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
[Intra-arterial infusion chemotherapy of locally advanced and recurrent breast cancer].
August 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
W Ichikawa, and T Osanai, and C Shimizu, and H Uetake, and S Iida, and T Yamashita, and N Nishi, and S Togo, and T Miyanaga, and Z Nihei, and K Sugihara
[Combination neoadjuvant therapy with continuous intra-arterial CDDP infusion and radiotherapy for locally advanced breast cancer].
September 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!